Search NLS News

Braincool announces that it is reporting its former CEO to the police over a prohibited loan, and that it will have to raise capital of SEK 85-95 million. The police report comes after ex-CEO Martin Waleij allegedly carried out a falsified payment on his own initiative, which was in fact a loan from the company […]

A SEK 7.7 million investment is being made into the BRIDGE Sweden project, designed to streamline the journey from research to commercialization of biological pharmaceuticals and precision medicine. Running for 3 years and supported by SweLife through the Swedish Innovation Agency, Vinnova, BRIDGE aims to create a development platform spanning from identifying drug candidates to […]

The company has received SEK 5 million from Eurostars in a collaborative project with the French biotech company Okomera. The funding is intended to strengthen the development of an analysis method for T-cell activity against the patient’s tumor. “We are very grateful for the support from Eurostars, which not only recognizes the scientific potential of […]

Sobi has announced results from the AVA-PED-301 study, evaluating the efficacy and safety of avatrombopag (Doptelet) for the treatment of paediatric patients with immune thrombocytopenia (ITP) of at least 6 months’ duration. The study enrolled 75 subjects between 1 and <18 years and the primary endpoint, durable platelet response, was met in 28% of avatrombopag […]

Novo Nordisk has agreed to acquire Cardior for up to EUR 1.025 billion, including an upfront payment and additional payments if certain development and commercial milestones are achieved. Cardior is a leader in the discovery and development of therapies that target RNA as a means to prevent, repair and reverse diseases of the heart. The […]

The company has been awarded up to EUR 10 million in grant and equity financing by the European Innovation Council (EIC) Accelerator program to support the company through key milestones leading to commercial launch and scale-up of its digital biomarker Histotype Px Colorectal. This milestone marks a breakthrough in the company’s journey to ensure personalized […]

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending marketing authorization for Awiqli (the brand name for once-weekly basal insulin icodec) for treatment of diabetes in adults. “We believe that by reducing the number of basal insulin injections from seven to one per week, Awiqli has […]

Nykode Therapeutics has announced key conclusions from the updated analysis from the Phase 2 VB-C-02 trial. The trial investigates the use of Nykode’s wholly-owned off-the-shelf therapeutic cancer vaccine candidate VB10.16 in combination with Roche’s checkpoint inhibitor atezolizumab in patients with recurrent or metastatic HPV16-positive cervical cancer. The updated results, which closely mirror the previously reported […]

International lessons in building the cell and gene therapy manufacturing workforce, from Seattle and the Nordic countries. The Nordic countries have a few things in common with the drippy, green Northwest corner of the United States. Settled partly by Scandinavian fishermen and loggers, Seattle claims to have the largest Norwegian Independence Day celebration outside of […]

Jeppe Øvlesen has been appointed new CEO, succeeding Torbjørn Bjerke, effective immediately due to a disagreement over the company’s strategy. The decision was reached following an extraordinary general meeting and after the first meeting by the new board of directors. “It has been a pleasure supporting SynAct from both the board of directors and as […]